Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.